Chargement en cours...

Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells

Recent findings show that exposure to temozolomide (TMZ), a DNA damaging drug used to treat glioblastoma, can suppress the conversion of pyruvate to lactate. To understand the mechanistic basis for this effect and its potential utility as a TMZ response biomarker, we compared the response of isogeni...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Res
Auteurs principaux: Park, Ilwoo, Mukherjee, Joydeep, Ito, Motokazu, Chaumeil, Myriam M., Jalbert, Llewellyn E., Gaensler, Karin, Ronen, Sabrina M., Nelson, Sarah J., Pieper, Russell O.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4253720/
https://ncbi.nlm.nih.gov/pubmed/25320009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-0849
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!